PacBio reports that through its partnership with China-headquartered Berry Genomics, the Sequel II CNDx system has received Class III Medical Device Registration approval from the National Medical ...
MENLO PARK, Calif. and PRETORIA, South Africa, April 20, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, ...
Zacks Investment Research on MSN
PacBio stock dips post latest launch to expand multiomics capabilities
Pacific Biosciences of California, Inc. PACB, popularly known as PacBio, announced a new community-developed method, CiFi, ...
(RTTNews) - PacBio (PACB), a developer of highly accurate sequencing solutions, is slated to participate in several upcoming investor conferences this month, underscoring its visibility within the ...
MENLO PARK, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PacBio (PACB), developer of the world's most advanced sequencing technologies, today announced that, through its long-standing partnership with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback